PLoS ONE · 2014 · 25 citations · 16 references
Hyperactivity in young SHRs can be improved by treatment with atomoxetine via the DA D2 pathway.
16
Frank P. Bymaster · Neuropsychopharmacology · 2002 · 1.1K citations · Full text
Neuropsychology, Psychoactive Drug, Attention Deficit/hyperactivity Disorder +12